FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STRYKER CORP

2. Date of Event Requiring Statement (MM/DD/YYYY)
12/18/2017 

3. Issuer Name and Ticker or Trading Symbol

ENTELLUS MEDICAL INC [ENTL]

(Last)        (First)        (Middle)

2825 AIRVIEW BOULEVARD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          ___ X ___ Other (specify below)
/ See Footnotes

(Street)

KALAMAZOO, MI 49002       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.001 par value per share   0   I   See Footnotes   (1) (2) (3)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)     (1) (2) (3)   (1) (2) (3) Common Stock, $0.001 par value per share   0.0     (1) (2) (3) I   See Footnotes   (1) (2) (3)

Explanation of Responses:
(1)  On December 7, 2017, Entellus Medical, Inc., a Delaware corporation (Issuer), entered into an Agreement and Plan of Merger (the Merger Agreement) with Stryker Corporation, a Michigan corporation (Stryker), and Explorer Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of Stryker (Merger Sub). The Merger Agreement provides that, upon the terms and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the Merger), with Issuer continuing as the surviving corporation and a wholly owned subsidiary of Stryker.
(2)  See exhibit 99.
(3)  Stryker does not have any pecuniary interest in any of the Shares

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
STRYKER CORP
2825 AIRVIEW BOULEVARD
KALAMAZOO, MI 49002
X
See Footnotes

Signatures
/s/ GLENN S. BOEHNLEIN 12/18/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos ENTELLUS MEDICAL INC.
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos ENTELLUS MEDICAL INC.